VOL 46 No. 1

Objectives To pilot efficacy and safety data of quetiapine-XR monotherapy or adjunctive therapy to antidepressant(s) in the acute treatment of MDD with current generalized anxiety disorder (GAD). Methods The Mini International Neuropsychiatric Interview was used...

Objectives The current study compares the risk of sexual pain in depressed female patients in remission between those who were treated with Escitalopram and Fluoxetine. The associated factors were also examined. Methods This is a...

Objectives To evaluate paliperidone palmitate (PP) effectiveness, safety and adherence to treatment. Methods We collected data of all patients (n = 50) affected by Schizophrenia Disorders, treated with PP for a 3 month minimum period...

Aims/objectives Psychotropic drugs are associated with significant short-term and long-term safety issues which may affect patients’ mental health, physical health and cost of care. Experimental designs This was a prospective study conducted in psychiatry department...

Pharmacogenetics is interested in the variable response to drugs depending on the genetic constitution of an individual. Depending on the genetic variation in individuals known as polymorphism; leads to differences in the types of proteins,...

Obsessive compulsive disorder (OCD) is characterized by recurrent, unwanted thoughts (obsessions) and/or repetitive behaviors (compulsions). Although selective serotonin reuptake inhibitors are widely used to treat OCD, only half of the patients respond well. Several potentiation...

Paroxetine, also known by the trade names Aropax, Paxil, Pexeva, Seroxat, Sereupin and Brisdelle, was first marketed in the U.S. in 1992. Effective for major depression and various anxiety disorders, it quickly gained a sizable...